Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23850296

FC(F)(F)c1ccc(C(F)(F)F)c(N2CC3(CNC3)C2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 5/20 0.52
▸ XPO1 O14980 2/20 0.43
▸ CES2 O00748 2/20 0.39
▸ CYP3A4 P08684 3/20 0.37
▸ USP2 O75604 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ FFAR1 O14842 2/20 0.37
▸ TTR P02766 2/20 0.37
▸ RBP4 P02753 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL23850306 0.79 ALDH1A1 (0.51) CYP3A4USP2HSD17B10GRIN1GRIN2B
Trifluoroacetic Acid SCHEMBL23850543 0.76 PKM (0.38) FFAR4CES2GRIN1GRIN2BMEN1
Trifluoroacetic Acid SCHEMBL29931781 0.73 SLC22A12 (0.37) FFAR4MEN1KMT2ANPY2R
Trifluoroacetic Acid SCHEMBL20510323 0.73 CYP2C19 (0.50) CYP3A4USP2HSD17B10CYP1A2CYP2C9
Trifluoroacetic Acid SCHEMBL1394390 0.72 SCD (0.42) FFAR4FFAR1
SCHEMBL23850299 0.70 FFAR4 (0.40) FFAR4XPO1CES2FFAR1MEN1
Trifluoroacetic Acid SCHEMBL20510269 0.69 CYP2C9 (0.51) CYP3A4USP2HSD17B10MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL29482892 0.69 CYP3A4 (0.38) CYP3A4USP2HSD17B10CYP1A2MAPT
SCHEMBL5802557 0.69 SERPINE1 (0.60) FFAR4XPO1CYP3A4CYP1A2MAPT
SCHEMBL19403771 0.69 ADRB2 (0.56) FFAR4XPO1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577257-B2 Heterocyclic compounds HOFFMANN-LA ROCHE INC. (US) 2026-03-17 — — US disclosed
EP-3883936-B1 NEW HETEROCYCLIC COMPOUNDS HOFFMANN LA ROCHE (CH) 2023-07-12 — — EP disclosed
US-20210387999-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-12-16 — — US disclosed
EP-3883936-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2021-09-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387999-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 FFAR4 4239/4885XPO1 369/4885CES2 585/4885
US-12577257-B2 Heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CBR3 FFAR4 3304/4885XPO1 630/4885CES2 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback